I can see the analyst changes data is showing primarily consensus target price adjustments and recommendation removals. Let me look at the data more carefully to find the most interesting individual analyst calls with significant changes.

Looking at this data, I see mostly consensus updates and recommendation removals. The most notable changes are:

• Microsoft (MSFT) - Target price down to $593.36 from $594.62
• Oracle (ORCL) - Target price down to $247.68 from $249.02

These are very minor changes. Let me check if there are more significant individual analyst actions in the full dataset by examining other rows that might show upgrades, downgrades, or initiations.

The data shows mostly small consensus adjustments rather than dramatic individual analyst calls. Let me create an article focusing on the pattern of medical device sector recommendation removals and the tech target price adjustments:

Medtech Sees Analyst Pruning Wave

Medical device stocks absorbed a wave of recommendation removals today. EW Edwards Lifesciences lost analyst coverage as consensus target edged down to $96.85 from $96.46. BDX Becton Dickinson saw similar coverage reduction with targets slipping to $196.08 from $197.15.

ISRG Intuitive Surgical dropped one buy recommendation. The surgical robot maker's consensus target fell to $605.08 from $606.53 across 34 analysts. ZBH Zimmer Biomet lost coverage as targets dipped to $102.33 from $102.65.

DXCM DexCom and PODD Insulet both shed recommendations. DexCom consensus held at $86.56 while Insulet stayed near $353.46 showing stable expectations despite coverage changes.

Tech giants absorbed minor target cuts. MSFT Microsoft consensus slipped to $593.36 from $594.62 across 54 analysts. ORCL Oracle dropped to $247.68 from $249.02 suggesting slight caution on enterprise software valuations.

The medical device sector dominated today's activity with systematic coverage adjustments rather than dramatic rating swings.